Cabaletta Bio, Inc. (CABA)
2.32
+0.13
(+5.94%)
USD |
NASDAQ |
Jan 21, 14:34
Cabaletta Bio Market Cap: 223.34M for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CorMedix, Inc. | 562.55M |
| Verastem, Inc. | 482.05M |
| Anavex Life Sciences Corp. | 466.40M |
| Ocugen, Inc. | 477.85M |
| Cartesian Therapeutics, Inc. | 194.51M |
Market Cap Related Metrics
| PEG Ratio | -0.0534 |
| Price to Book Value | 1.601 |
| Price | 2.32 |
| Earnings Yield | -108.9% |
| PEGY Ratio | -0.0534 |